Maurizio Averna - Concepedia

Author

Maurizio Averna

Also Known As

Antonina Giammanco, Averna M, Averna, Maurizio R, Francesco Angelico, G. Kees Hovingh, H. N. Ginsberg, M AVERNA, M Averna, M R Averna, M. AVERNA

782

Publications

23.1K

Citations

H-Index

148

Concepts

All Affiliations

University of Palermo Sapienza University of Rome University of Milan University of Modena and Reggio Emilia MultiMedica

About

Maurizio Averna is an author at University of Palermo specializing in medicine, atherosclerosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	100	5.7K
2	Public Health	22	39	1.9K
3	Health Sciences	15	19	1.6K
4	Natural Sciences	1	1	15
5	Allergy	1	1	32

Maurizio Averna

190

Publications

17K

Citations

H-Index

Page 1

	Year	Citations
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society Børge G. Nordestgaard, M. John Chapman, Steve E. Humphries, European Heart Journal	2013	2.7K
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events Jennifer G. Robinson, Michel Farnier, Michel Krempf, New England Journal of Medicine	2015	2.3K
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society Marina Cuchel, Éric Bruckert, Henry N. Ginsberg, European Heart Journal	2014	1K
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society Henry N. Ginsberg, Chris J. Packard, M. John Chapman, European Heart Journal Vascular DiseaseHyperlipidemiaTriglyceride-rich LipoproteinsTrl RemnantsMetabolic Syndrome	2021	804
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study Marina Cuchel, Emma A. Meagher, Hendrik du Toit Theron, The Lancet Metabolic SyndromeLipid DisorderHomozygous Familial HypercholesterolaemiaCardiovascular DiseaseMedicine	2012	728
Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus Isabella Catalano, Maurizio Averna, A Notarbartoló, New England Journal of Medicine	1990	597
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons, The Lancet Family MedicineMetabolic SyndromeLipid DisorderCardiovascular DiseaseHealth Policy	2021	285
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance Marina Cuchel, Frederick J. Raal, Robert A. Hegele, European Heart Journal	2023	280
Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa Hypercholesterolemia A Notarbartoló, Giovanni Davı̀, Maurizio Averna, Arteriosclerosis Thrombosis and Vascular Biology	1995	260
Diagnostic Accuracy of Fecal Calprotectin Assay in Distinguishing Organic Causes of Chronic Diarrhea from Irritable Bowel Syndrome: A Prospective Study in Adults and Children Antonio Carroccio, Giuseppe Iacono, Mario Cottone, Clinical Chemistry	2003	222

Page 1